| 摘要 |
The subject matter of the invention is the use, as a medicament or medical nutrition product in humans, for the treatment of pathological dysbiosis and/or for the prevention or treatment of at least one derived metabolic disease chosen from excess weight with co-morbidity, obesity, diabetes, cardiac and vascular diseases, atherosclerosis, degenerative bone diseases, neurodegenerative diseases, metabolism-related cancers, autoimmune diseases, steatosis, metabolic steatohepatitis and chronic inflammatory bowel diseases, by increasing the bacterial genus Christensenella in the intestine, of a composition comprising a mixture of active ingredients made up of at least: - a hydrolysate of whey having a molecular weight of between 200 and 10 000 daltons, - a whey isolate and/or concentrate, and - calcium caseinate. |
